Home > Resources > Company Profiles > Targacept, Incorporated > News

Targacept, Incorporated (TRGT)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Dr. J. Donald deBethizy, Ph.D. , CEO/President/Director
Industry: Healthcare
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Dr. J. Donald deBethizy, Ph.D., CEO/President/Director

200 East First Street

Suite 300

Winston-Salem, NC 27101

US Map it

Phone: (336) 480-2100

Fax: (336) 480-2107

www.targacept.com

Latest news from Portfolio


Overview

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics(tm), a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Portfolio Articles
  • The Ultimare Cure
    The neurotech industry is engaged in a $2 trillion race to fix your brain. Many players will fail, but the payoff will be huge for those who succeed.
    May 12 2008

See more news on this company

News From Around the Web
News
powered by inform

Employees

Number of Employees: 100
Revenue per Employee: $379,128

Top Executives

Dr.Geoffrey C. Dunbar, M.D., Divisional Vice President
Peter A. Zorn, Divisional Vice President/General Counsel/Secretary
Jeffrey P. Brennan, Divisional Vice President

Alan A. Musso, CPA, CFO/Vice President/Treasurer/Assistant Secretary
Dr. William S. Caldwell, Ph.D., Divisional Vice President
Dr.Merouane Bencherif, M.D., Ph.D., Divisional Vice President

Board of Directors

Mark Skaletsky, Chairman of the Board/Director
Peter A. Zorn, Divisional Vice President/General Counsel/Secretary
Julia R. Brown, Director

Alan A. Musso, CPA, CFO/Vice President/Treasurer/Assistant Secretary
Charles A. Blixt, Director
Dr.Errol B. De Souza, Ph.D., Director

Financials

Quarterly
Annual

Income Statement 11/2008 08/2008 05/2008 03/2008
Sales 183 -281.2 K. -173.95 K. -99.06 K.
Gross Operating Profit 3.95 K. 5.44 Mil. 4.45 Mil. 3.66 Mil.
Operating Income before D & A (EBITDA) -8.16 K. -6.97 Mil. -6.32 Mil. -8.38 Mil.
Total Income Before Interest Expenses (EBIT) -7.65 K. -6.73 Mil. -5.73 Mil. -7.6 Mil.
Total Net Income -7.65 K. -6.8 Mil. -5.78 Mil. -7.65 Mil.
Basic EPS, Total -0.31 -0.27 -0.24 -0.37
Diluted EPS, Total -0.31 -0.27 -0.24 -0.37

BALANCE STATEMENT 11/2008 08/2008 05/2008 03/2008
Cash and Equivalents 93.75 K. 64.37 Mil. 65.47 Mil. 53.4 Mil.
Total Assets NA 106.83 Mil. 97.53 Mil. 92.41 Mil.
Total Liabilities 14.23 K. 14.09 Mil. 13.59 Mil. 15.2 Mil.
Total Capitalization 62.26 K. 72.98 Mil. 79.23 Mil. 53.27 Mil.

Cash Flow 11/2008 08/2008 05/2008 03/2008
Net Cash From Continuing Operations NA -15.14 Mil. -6.72 Mil. 24.84 Mil.
Net Cash From Investing Activities NA -5.63 Mil. -13.29 Mil. -26.29 Mil.
Net Cash From Financing Activities NA 31.73 Mil. 32.08 Mil. 13.11 Mil.
Net Change in Cash & Cash Equivalents NA 10.96 Mil. 12.06 Mil. 11.66 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006
Sales -191.74 K. -363.67 K. -322.25 K.
Gross Operating Profit 11.77 Mil. 27.9 Mil. 1.5 Mil.
Operating Income before D & A (EBITDA) -30.86 Mil. 417.23 K. -29.14 Mil.
Total Income Before Interest Expenses (EBIT) -27.93 Mil. 2.18 Mil. -28.77 Mil.
Total Net Income -28.07 Mil. 2.1 Mil. -28.99 Mil.
Basic EPS, Total -1.42 -0.09 -153.54
Diluted EPS, Total -1.42 -0.09 -153.54

BALANCE STATEMENT 2008 2007 2006
Cash and Equivalents 53.4 Mil. 41.74 Mil. 24.85 Mil.
Total Assets 92.41 Mil. 78.85 Mil. 25.74 Mil.
Total Liabilities 15.2 Mil. 8.95 Mil. 5.21 Mil.
Total Capitalization 53.27 Mil. 65.81 Mil. -161.07 Mil.

Cash Flow 2008 2007 2006
Net Cash From Continuing Operations 24.84 Mil. -9.89 Mil. -26.25 Mil.
Net Cash From Investing Activities -26.29 Mil. -13.27 Mil. -250.25 K.
Net Cash From Financing Activities 13.11 Mil. 40.05 Mil. -1.73 Mil.
Net Change in Cash & Cash Equivalents 11.66 Mil. 16.89 Mil. -28.22 Mil.

powered by Interactive Data







News Volume

31 days volume

100%
80%
60%
40%
20%
0
October
November

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented